Nervonik Announces $52.5M Series B Financing

Nervonik closed an oversubscribed $52.5 million Series B financing.

The round was led by Amzak Health, with participation from Elevage Medical Technologies, U.S. Venture Partners, Lumira Ventures, Foothill Ventures, and Shangbay Capital.

The funding will help advance and commercialize Nervonik’s next-generation peripheral nerve stimulation devices.

The deal signals continued investor interest in clinical-stage medical device companies.